Literature DB >> 12205009

Two cases of biceps injury in bodybuilders with initially misleading presentation.

F Dunn1.   

Abstract

Two cases are reported of biceps injuries in body builders. In both cases the mechanism of injury is either unclear or initially misleading. One case went on to develop necrotising fasciitis, requiring extensive debridement after an initial diagnosis of a biceps haematoma. This report emphasises the difficulties inherent in differentiating necrotising and non-necrotising infections in the emergency department setting and highlights a subgroup of patients who may be at particular risk of delayed diagnosis.

Entities:  

Mesh:

Year:  2002        PMID: 12205009      PMCID: PMC1725952          DOI: 10.1136/emj.19.5.461

Source DB:  PubMed          Journal:  Emerg Med J        ISSN: 1472-0205            Impact factor:   2.740


  4 in total

1.  Coagulase-positive staphylococcal necrotizing fasciitis subsequent to shoulder sprain in a healthy woman.

Authors:  Hyeung-June Kim; Dong-Heon Kim; Duk-Hwan Ko
Journal:  Clin Orthop Surg       Date:  2010-11-05

2.  Injection site infections and injuries in men who inject image- and performance-enhancing drugs: prevalence, risks factors, and healthcare seeking.

Authors:  V D Hope; J McVeigh; A Marongiu; M Evans-Brown; J Smith; A Kimergård; J V Parry; F Ncube
Journal:  Epidemiol Infect       Date:  2014-04-08       Impact factor: 4.434

3.  Isolated spontaneous biceps abscess causing septic shock in a diabetic patient: A rare case report.

Authors:  M Masood Sidiqi; Benjamin Witte
Journal:  Int J Surg Case Rep       Date:  2020-08-07

4.  Prevalence of, and risk factors for, HIV, hepatitis B and C infections among men who inject image and performance enhancing drugs: a cross-sectional study.

Authors:  Vivian D Hope; Jim McVeigh; Andrea Marongiu; Michael Evans-Brown; Josie Smith; Andreas Kimergård; Sara Croxford; Caryl M Beynon; John V Parry; Mark A Bellis; Fortune Ncube
Journal:  BMJ Open       Date:  2013-09-12       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.